Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for CRL, sign up here.
Income Statement
Revenue
$4.1bn
Gross Profit
$1.5bn
Earning before Tax
$575.5m
Net Income
$474.6m
Net Income Common Shareholders
$474.6m
EPS
9.27
Balance Sheet
Cash
$276.8m
Debt
$3.1bn
Assets
$8.2bn
Liabilities
$4.5bn
Equity
$3.6bn
Enterprise Value
$14.9bn
Cash Flow Statement
Net Cash from Operations
$683.9m
Net Cash from Investing
$-0.6bn
Net Cash from Financing
$-85.5m
Net Cash Flow
$43.3m
Free Cash Flow
$365.4m
Free Cash Flow per Share
$7.13
Metrics
Price to Equity
25.55
Price to Equity (Damodaran)
25.50
Price to Book
3.37
Net Margin
0.12
Return on Equity
0.14
Return on Sales
0.17
Get immediate access to 5-years of reference grade data for CRL for free.
Sign upCharles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Company Info
Industry
Diagnostics & Research
Employees
20,000
Address
251 Ballardvale Street
Wilmington, MA 01887
United States
Phone
781 222 6000
Website
Last Updated
2024-02-08
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.